For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Beatling on: He may be a dreamer,
Wednesday 13 March 2019, 06:30 AM

Dutch reforms harvest controlled rising healthcare costs
Others have tried big-scale health reforms. Tim Tenbensel checks out the Dutch health reforms
It’s sobering that the Dutch story is the only example of blueprint health-policy change in the four countries over a 70-year period
Imagine you’
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.